Jazz Pharmaceuticals PLC JAZZ:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/23/21 EDT
176.98quote price arrow down-0.32 (-0.18%)
Volume
523,154
52 week range
103.45 - 189.00

...

Loading . . .
  • Open177.06
  • Day High177.86
  • Day Low174.35
  • Prev Close176.98
  • 52 Week High189.00
  • 52 Week High Date06/15/21
  • 52 Week Low103.45
  • 52 Week Low Date07/09/20

Key Stats

  • Market Cap10.792B
  • Shares Out60.98M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change7.23

KEY STATS

  • Open177.06
  • Day High177.86
  • Day Low174.35
  • Prev Close176.98
  • 52 Week High189.00
  • 52 Week High Date06/15/21
  • 52 Week Low103.45
  • 52 Week Low Date07/09/20
  • Market Cap10.792B
  • Shares Out60.98M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change7.23

RATIOS/PROFITABILITY

  • EPS (TTM)9.11
  • P/E (TTM)19.43
  • Fwd P/E (NTM)12.52
  • EBITDA (MRQ)1.014B
  • ROE (MRQ)15.69%
  • Revenue (MRQ)2.436B
  • Gross Margin (MRQ)93.41%
  • Net Margin (MRQ)21.23%
  • Debt To Equity (MRQ)55.34%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jazz Pharmaceuticals PLC

Profile

MORE
Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with...
Bruce Cozadd
Chairman
Daniel Swisher Jr.
President
Renee Gala
Chief Financial Officer
Patricia Carr
Chief Accounting Officer
Kimberly Sablich
Executive Vice President
Address
Fifth Fl
Waterloo Exchange, Waterloo Road
Dublin
4
Ireland